I think it's very fair and constructive to say again that Ocata is in a desperate financial situation and truly non-functioning by FDA yardsticks, without getting financially stabilized to successfully start and finish their phase 2. That is the 'tail wagging the dog', and money the 'heart' needs to keep it alive and Ocata potentially going anywhere, imo.
To that extent, it's sad that we've been given such a paucity of hard news on recent shares actually sold and their pricing, etc.
Even of the information shared with us, all are hedge firms, whose objectives and tactics are not in the best interests of investors, to say the least. Lets not fool ourselves. No fund manager is going to invest millions in such a troubled stock at this stage in it's development as a fundamentally sound holding for it's portfolio.
Assuming wotton hasn't gotten the dollars hoped for in the last share sale (which, even if totally successful was nowhere enough anyways for a complete phase 2), which sounds like a pretty safe assessment given the lack of news, my guess is Lincoln very much remains in the picture and shortly more shares and more dilution seem inevitable.
Ocata MUST start a phase 2. Period and that means new desperate action.
Sadly, to me we clearly are moving below 5.00, probably way below factoring in all the above as we head into expected turbulent markets all buffeted by hedge fund action negatively effecting Ocata.
